hGH Fragment 176-191 6mg

PEPTAS catalog record

About hGH Fragment 176-191 6mg

The name hGH Fragment 176-191 identifies a peptide by reference to a sequence region of human growth hormone. Region-based names can conceal differences in terminal chemistry, added residues, modifications, or numbering conventions, so the exact sequence should be checked against the current item documentation.

This PEPTAS listing carries a nominal amount of 6mg for controlled research procurement. It does not represent full-length human growth hormone and must not be described, handled, or used as a medicine, diagnostic, supplement, or material for administration to a person or animal.

hGH Fragment 176-191 is closely related to AOD-9604, which PEPTAS lists separately at the same nominal amount. The two are distinct catalog identities with their own registry numbers (CAS 66004-57-7 for the fragment, CAS 221231-10-3 for AOD-9604) and reported compositions that differ by a single oxygen atom, and they are not interchangeable. Selection should follow the project’s own specification and acceptance criteria rather than the similarity of the names.

Planning work with this material

When reproducing or comparing research, record the sequence exactly as supplied rather than relying only on the 176-191 shorthand. Confirm terminal form, counterion, analytical method, and any modification relevant to the project, then establish incoming criteria before opening the package.

Keep the item identifier, lot, receipt condition, storage record, and preparation history together. If an image, label, or supporting record does not agree with the accepted order, treat the issue as a documentation discrepancy and contact PEPTAS.

Documentation and order review

Availability, product identity, listed quantity, price, packaging, transport terms, storage information, and any supporting analytical documents are confirmed for the actual item or accepted order. Request the information your project requires before purchasing; a general catalog page cannot replace an order-specific specification or certificate.

• Confirm purchaser eligibility, destination rules, permits, and institutional approvals.
• Define identity and analytical acceptance criteria before the material is received.
• Inspect the package, identifier, quantity, lot information, and documents on arrival.
• Maintain controlled access, storage, preparation, traceability, and disposal records.

Research-use conditions

Not for human or veterinary use. This material is not a medicine, food, dietary supplement, cosmetic, diagnostic product, or household product. It must not be administered, consumed, compounded for administration, used for self-experimentation, or represented as suitable for the diagnosis, treatment, mitigation, cure, or prevention of any condition.

Purchasers are responsible for lawful acquisition and use, competent risk assessment, suitable facilities and personnel, appropriate personal protective equipment, validated procedures, security, incident response, and waste disposal. Website information is not medical, veterinary, legal, regulatory, or scientific-protocol advice.